Valeriu Crudu

4.3k total citations
55 papers, 1.0k citations indexed

About

Valeriu Crudu is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Valeriu Crudu has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Infectious Diseases, 48 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in Valeriu Crudu's work include Tuberculosis Research and Epidemiology (49 papers), Mycobacterium research and diagnosis (30 papers) and Pneumonia and Respiratory Infections (17 papers). Valeriu Crudu is often cited by papers focused on Tuberculosis Research and Epidemiology (49 papers), Mycobacterium research and diagnosis (30 papers) and Pneumonia and Respiratory Infections (17 papers). Valeriu Crudu collaborates with scholars based in United States, Germany and Moldova. Valeriu Crudu's co-authors include Ted Cohen, Donald G. Catanzaro, Timothy C. Rodwell, Camilla Rodrigues, Elena Romancenco, Antonino Catanzaro, Caroline Colijn, Sophia B. Georghiou, Barun Mathema and Jennifer L. Gardy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Valeriu Crudu

49 papers receiving 1.0k citations

Peers

Countries citing papers authored by Valeriu Crudu

Since Specialization

Citations

This map shows the geographic impact of Valeriu Crudu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valeriu Crudu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valeriu Crudu more than expected).

Fields of papers citing papers by Valeriu Crudu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valeriu Crudu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valeriu Crudu. The network helps show where Valeriu Crudu may publish in the future.

Co-authorship network of co-authors of Valeriu Crudu

This figure shows the co-authorship network connecting the top 25 collaborators of Valeriu Crudu. A scholar is included among the top collaborators of Valeriu Crudu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valeriu Crudu. Valeriu Crudu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic accuracy study of STANDARD TB-Feron FIA and STANDARD TB-Feron ELISA tests for tuberculosis infection diagnosis in Eastern European setting 2025 ·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ·Valeriu Crudu, Dumitru Chesov, (unknown), (unknown), (unknown), (unknown), Doina Rusu	0
2	Quantifying uncertainty in deep learning binary classification with discrete noise in inputs for risk-based decision making 2025 ·IISE Transactions ·(unknown), (unknown), Donald G. Catanzaro, Valeriu Crudu	0
3	A new method for detecting mixed Mycobacterium tuberculosis infection and reconstructing constituent strains provides insights into transmission 2025 ·Genome Medicine ·Benjamin Sobkowiak, Patrick Cudahy, Melanie H. Chitwood, Taane G. Clark, Caroline Colijn, Louis Grandjean, Katharine S. Walter, Valeriu Crudu, Ted Cohen	0
4	High rates of acquired resistance to fluoroquinolones, bedaquiline, and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of Moldova 2025 ·Clinical Microbiology and Infection ·Dumitru Chesov, Maja Reimann, (unknown), (unknown), (unknown), (unknown), Doina Rusu, (unknown), Valeriu Crudu, Christoph Lange	0
5	DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis 2025 ·BMC Infectious Diseases ·Nestani Tukvadze, (unknown), Anne K. Jacobs, (unknown), Norbert Heinrich, Annelies Van Rie, Valeriu Crudu, Elena Tudor, (unknown), Elmira Ibraim, Celso Khosa, Pauline Howell, (unknown), Kogieleum Naidoo, Stefan Niemann, Klaus Reither, Robert S. Wallis	1
6	Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017–2022 2024 ·Emerging infectious diseases ·Victor Næstholt Dahl, (unknown), Alex Rosenthal, (unknown), Andrei Gabrielian, Sergo Vashakidze, Natalia Shubladze, (unknown), (unknown), Valeriu Crudu, Dumitru Chesov, (unknown), (unknown), Christian Wejse, Dmytro Butov, (unknown)	4
7	Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis 2024 ·PLoS Medicine ·Lyndon P. James, Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F. Franke, Reza Yaesoubi, Dumitru Chesov, (unknown), (unknown), Valeriu Crudu, Ted Cohen, Nicolas A. Menzies	4
8	The recent rapid expansion of multidrug resistant Ural lineage Mycobacterium tuberculosis in Moldova 2024 ·Nature Communications ·Melanie H. Chitwood, Caroline Colijn, Chongguang Yang, Valeriu Crudu, (unknown), (unknown), Jaehee Kim, (unknown), Kyu Y. Rhee, Ted Cohen, Benjamin Sobkowiak	7
9	Acute phase proteins and IP-10 in plasma for tuberculosis diagnosis 2023 ·Bárbara Molina-Moya, Raquel Villar-Hernández, (unknown), (unknown), Alícia Lacoma, (unknown), Irene Latorre, (unknown), Cristina Prat, Valeriu Crudu, Konstantina Kontogianni, Luís E. Cuevas, José Domínguez	1
10	Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis 2022 ·Nature Communications ·Matthias Merker, Jean‐Philippe Rasigade, Maxime Barbier, Helen Cox, Silke Feuerriegel, Thomas A. Kohl, Egor Shitikov, (unknown), Cyril Gaudin, Rudy Antoine, Roland Diel, Sònia Borrell, Sébastien Gagneux, Vladyslav Nikolayevskyy, Sönke Andres, Valeriu Crudu, Philip Supply, Stefan Niemann, Thierry Wirth	38
11	Evolution and emergence of multidrug-resistant Mycobacterium tuberculosis in Chisinau, Moldova 2021 ·Microbial Genomics ·Tyler S. Brown, Vegard Eldholm, Ola Brynildsrud, (unknown), Natalie S. Levy, James Stimson, Caroline Colijn, Sofia Alexandru, Ecaterina Noroc, (unknown), Valeriu Crudu, Ted Cohen, Barun Mathema	8
12	Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Samples Using a Novel Tabletop Platform: Protocol for a Prospective Clinical Study 2021 ·JMIR Research Protocols ·(unknown), Marva Seifert, Donald G. Catanzaro, (unknown), Rebecca E. Colman, Peter G. Chiles, Dumitru Chesov, (unknown), (unknown), Valeriu Crudu, Antonino Catanzaro, Timothy C. Rodwell	2
13	Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study 2021 ·The Lancet Infectious Diseases ·Adam Penn‐Nicholson, Sophia B. Georghiou, (unknown), Mubin Kazi, Manpreet Bhalla, Anura David, Francesca Conradie, Morten Rühwald, Valeriu Crudu, Camilla Rodrigues, Vithal Prasad Myneedu, Lesley Scott, Claudia M. Denkinger, Samuel G. Schumacher	66
14	Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country 2020 ·European Respiratory Journal ·Dumitru Chesov, Jan Heyckendorf, Sofia Alexandru, (unknown), (unknown), Maja Reimann, Valeriu Crudu, Victor Botnaru, Christoph Lange	18
15	THE CORRELATION BETWEEN LEVELS OF PHENOTYPIC RESISTANCE AND GENOTYPIC MUTATIONS OF M. TUBERCULOSIS 2018 ·Russian Journal of Infection and Immunity ·(unknown), Sofia Alexandru, Dumitru Chesov, (unknown), Christoph Lange, Valeriu Crudu	0
16	Cost analysis of rapid diagnostics for drug-resistant tuberculosis 2018 ·BMC Infectious Diseases ·Erik J. Groessl, Théodore G. Ganiats, (unknown), André Trollip, (unknown), Donald G. Catanzaro, Timothy C. Rodwell, Richard S. Garfein, Camilla Rodrigues, Valeriu Crudu, Thomas C. Victor, Antonino Catanzaro	11
17	Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis 2018 ·Clinical Microbiology and Infection ·Victor Santana Santos, Delia Goletti, Konstantina Kontogianni, Emily R. Adams, Bárbara Molina-Moya, José Domínguez, Valeriu Crudu, Paulo Ricardo Martins‐Filho, Morten Rühwald, Lovett Lawson, (unknown), Alberto L. García‐Basteiro, Linda Petrone, Basirudeen Syed Ahamed Kabeer, Klaus Reither, Luís E. Cuevas	34
18	Armed conflict and population displacement as drivers of the evolution and dispersal of Mycobacterium tuberculosis 2016 ·Proceedings of the National Academy of Sciences ·Vegard Eldholm, John H.‐O. Pettersson, Ola Brynildsrud, Andrew Kitchen, Erik Michael Rasmussen, Troels Lillebæk, (unknown), Valeriu Crudu, Anne Torunn Mengshoel, (unknown), Kristian Alfsnes, Jon Bohlin, Caitlin S. Pepperell, François Balloux	54
19	Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing 2015 ·PLoS ONE ·Rebecca E. Colman, James M. Schupp, Nathan Hicks, (unknown), (unknown), Faramarz Valafar, Valeriu Crudu, Elena Romancenco, Ecaterina Noroc, (unknown), Donald G. Catanzaro, Timothy C. Rodwell, Antonino Catanzaro, Paul Keim, David M. Engelthaler	70
20	Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country 2012 ·European Respiratory Journal ·Helen E. Jenkins, (unknown), (unknown), Valeriu Crudu, (unknown), (unknown), (unknown), Matteo Zignol, Andrei Dadu, Masoud Dara, Ted Cohen	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact